Renninger Robert bought ATHA
March 3, 2025 · Form 4 insider transaction
Renninger Robert bought 39,000 shares of Athira Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
39,000
Price
$0.00
Total value
N/A
InsiderRenninger Robert
RoleOfficer
CompanyAthira Pharma, Inc. (ATHA)
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 3, 2025
Filing dateMarch 4, 2025
Shares owned after39,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.; 100% of the RSUs shall vest on the one (1) year anniversary of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the vesting date.